Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Avidity Biosciences (RNA) Return on Assets (2020 - 2025)

Historic Return on Assets for Avidity Biosciences (RNA) over the last 6 years, with Q3 2025 value amounting to 0.31%.

  • Avidity Biosciences' Return on Assets fell 1300.0% to 0.31% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.31%, marking a year-over-year decrease of 1300.0%. This contributed to the annual value of 0.29% for FY2024, which is 400.0% up from last year.
  • According to the latest figures from Q3 2025, Avidity Biosciences' Return on Assets is 0.31%, which was down 1300.0% from 0.32% recorded in Q2 2025.
  • In the past 5 years, Avidity Biosciences' Return on Assets ranged from a high of 0.19% in Q3 2024 and a low of 0.38% during Q3 2022
  • Its 5-year average for Return on Assets is 0.29%, with a median of 0.3% in 2022.
  • Its Return on Assets has fluctuated over the past 5 years, first plummeted by -1600bps in 2021, then surged by 1500bps in 2024.
  • Quarter analysis of 5 years shows Avidity Biosciences' Return on Assets stood at 0.28% in 2021, then decreased by -18bps to 0.33% in 2022, then decreased by -8bps to 0.35% in 2023, then soared by 43bps to 0.2% in 2024, then crashed by -56bps to 0.31% in 2025.
  • Its Return on Assets stands at 0.31% for Q3 2025, versus 0.32% for Q2 2025 and 0.24% for Q1 2025.